✦ LIBER ✦

Chemotherapy in patients who fail radiotherapy for diffuse aggressive non-hodgkin's lymphoma

✍ Scribed by James O. Armitage; B-Chen Wen

Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 571 KB
Volume: 13
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(87)90228-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HOAP-Bleo as salvage therapy for diffuse

HOAP-Bleo as salvage therapy for diffuse aggressive non-Hodgkin's lymphoma

✍ R. Liang; D. Todd; T. K. Chan 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 254 KB

A total of 30 patients with recurrent or unresponsive diffuse, aggressive non-Hodgkin's lymphoma, who had previously received doxorubicin, cyclophosphamide, vincristine, and prednisone with or without bleomycin were treated with a combination of doxorubicin, vincristine, ara C, prednisone, and bleom

T-cell non-hodgkin's lymphoma after radi

T-cell non-hodgkin's lymphoma after radiotherapy and chemotherapy for hodgkin's disease

✍ Raymond M. Lowenthal; Roger W. H. Harlow; Anne E. Mead; Deirdre Tuck; David R. C 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 539 KB

Outcomes and diffusion of doxorubicin-ba

Outcomes and diffusion of doxorubicin-based chemotherapy among elderly patients with aggressive non-Hodgkin lymphoma

✍ Victor R. Grann; Dawn Hershman; Judith S. Jacobson; Wei-Yann Tsai; Jian Wang; Ru 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Radiotherapy as salvage treatment in pat

Radiotherapy as salvage treatment in patients with hodgkin's disease or non-hodgkin's lymphoma relapsing after initial chemotherapy

✍ Carine Kirkove; Adrian R. Timothy 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

## Abstract The prognosis of relapsing Hodgkin's disease (HD) and high grade aggressive non‐Hodgkin's lymphoma (NHL) is generally poor since many of these patients fail to respond to second line chemotherapy. Radiation therapy has been reported as an effective but seldom used, alternative treatment

Mitoxantrone, prednimustine, and vincris

Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphoma

✍ Yau, Jonathan C.; Germond, Colin; Gluck, Stefan; Cripps, Christine; Verma, Shail 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

Elderly patients with intermediate-or high-grade non-Hodgkin's lymphoma have a worse outcome than those who are younger than 60 years. It has been shown that aggressive combination chemotherapy is poorly tolerated in older patients resulting in a subsequent decrease in dose intensity. A phase II tri

Primary chemotherapy followed by radioth

Primary chemotherapy followed by radiotherapy for localized non-hodgkin's lymphomas: A preliminary report

✍ Sampi, Kazumi ;Takeoda, Syozi ;Hattori, Masao 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB

## Abstract Twenty‐eight evaluable patients with clinical stage I‐II of non‐Hodgkin's lymphoma were treated with primary chemotherapy followed by involved field radiotherapy. The frequency of the follicular versus diffuse histological pattern was 14.3 versus 85.7%, and 24/28 (86%) of patients were